Trials / Unknown
UnknownNCT03654144
Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Adenomyosis was first described as endometrial glands in the myometrium of the uterus. The current definition of adenomyosis is provided in 1972 'the benign invasion of endometrium into the myometrium, producing a diffusely enlarged uterus which microscopically exhibits ectopic non-neoplastic, endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dienogest | oral tablets |
| DRUG | Combined Oral Contraceptive | oral tablets |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-12-01
- Completion
- 2020-03-01
- First posted
- 2018-08-31
- Last updated
- 2018-08-31
Source: ClinicalTrials.gov record NCT03654144. Inclusion in this directory is not an endorsement.